شرکت گروه دارویی برکت
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
بدون نتیجه
مشاهده تمام نتایج
شرکت گروه دارویی برکت
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
  • Media
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
صفحه اصلی Scientific Articles

Evaluation of the neutralizing properties of Iran Koo vaccine on disturbing variants of Corona virus

bpharmed توسط bpharmed
24 فروردین 1401
در Scientific Articles
0 0
A A
0
Evaluation of the neutralizing properties of Iran Koo vaccine on disturbing variants of Corona virus
0
اشتراک گذاری ها
54
بازدیدها

The first article in the clinical study of Bovine Bovine, entitled Evaluation of the Neutralizing Properties of the Bovine Vaccine on Disturbing Variants of the Coronavirus, was published in one of the world’s most prestigious journals, Clinical Microbiology and Infection.

According to this magazine, in terms of impact factor, this magazine is one of the top five magazines in the world in the field of infectious diseases.

In addition to this article, five other articles from clinical studies of Kaviran Barakat vaccine are under review or about to be published.

The results of preclinical studies have already been published. Animal studies of the omicron variant have also been printed in print.

پست قبلی

“Barakat” received a license to increase its capital by 27%

پست‌ بعدی

The result of a scientific study on the effectiveness of the Barakat vaccine

bpharmed

bpharmed

پست‌ بعدی

The result of a scientific study on the effectiveness of the Barakat vaccine

دیدگاهتان را بنویسید لغو پاسخ

نشانی ایمیل شما منتشر نخواهد شد. بخش‌های موردنیاز علامت‌گذاری شده‌اند *

Latest News

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

The specific vaccine “omicron” is produced by Iranian scientists

The result of a scientific study on the effectiveness of the Barakat vaccine

“Barakat” received a license to increase its capital by 27%

Take a look at the portfolio of Barakat Pharmaceutical Group in January

Shareholders read “Barakat” (January 7) / Price drop for the third day in a row

Barkat Pharmaceutical Group is one of the largest pharmaceutical holding Companies with more than 20 subsidiaries. The company’s name was was changed to “Tadbir innovation pharmaceutical company” in 2010.

Latest News

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

14 آذر 1401
The scientific article of phase one and two of Bovine Bovine vaccine was published in BMJ open journal

The scientific article of phase one and two of Bovine Bovine vaccine was published in BMJ open journal

14 خرداد 1401

Contact Us

Address : No. 11, 5th Alley, Bucharest Ave, Argentina Sq, Tehran, Iran

Phone :  +98 21 88480161

Email : info@bpharmed.com

Email Affairs Stock : stock@bpharmed.com

Follow Us

Copyright © 2020-2025 by www.bpharmed.com All Rights Reserved
powered by ravian

  • Subsidiaries
  • About Us
  • Contact Us
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian

Copyright © 2020-2025 by www.bpharmed.com All Rights Reserved
powered by ravian

خوش آمدید!

به حساب خود در زیر وارد شوید

رمز عبور را فراموش کرده اید؟

رمز عبور خود را بازیابی کنید

لطفا نام کاربری یا آدرس ایمیل خود را برای بازنشانی رمز عبور خود وارد کنید.

ورود به سیستم

Add New Playlist